Fig. 6From: Liraglutide attenuates type 2 diabetes mellitus-associated non-alcoholic fatty liver disease by activating AMPK/ACC signaling and inhibiting ferroptosisFerrostatin-1 (Fer-1) prevents T2DM-induced liver injury. The effect of Fer-1 on A body weight (BW) (n = 6) and B fast blood glucose (FBG) (n = 6). C, D Serum levels of ALT and AST in mice were detected (n = 4). E Histopathological changes were examined by H&E staining. Scale bar = 100 μm. F–H Serum levels of TC, TG and LDL-C in mice were detected (n = 4). Data are expressed as mean ± SD, *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, ns means no significant differenceBack to article page